Literature DB >> 32385536

Oligogenicity, C9orf72 expansion, and variant severity in ALS.

Jay P Ross1,2, Claire S Leblond3, Sandra B Laurent2,4, Dan Spiegelman2,4, Alexandre Dionne-Laporte2,4, William Camu5, Nicolas Dupré6,7, Patrick A Dion2,4, Guy A Rouleau8,9,10.   

Abstract

"Oligogenic inheritance" is used to describe cases where more than one rare pathogenic variant is observed in the same individual. While multiple variants can alter disease presentation, the necessity of multiple variants to instigate pathogenesis has not been addressed in amyotrophic lateral sclerosis (ALS). We sequenced ALS-associated genes in C9orf72-expansion-positive and negative ALS patients, alongside unaffected controls, to test the importance of oligogenicity and variant deleteriousness in ALS. We found that all groups had similar numbers of rare variants, but that variant severity was significantly higher in C9orf72-negative ALS cases, suggesting sufficiency of C9orf72 expansion to cause ALS alone.

Entities:  

Keywords:  ALS; C9orf72 expansion; Oligogenicity; Variant severity

Mesh:

Substances:

Year:  2020        PMID: 32385536     DOI: 10.1007/s10048-020-00612-7

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  3 in total

1.  Amyotrophic Lateral Sclerosis Genetic Access Program: Paving the Way for Genetic Characterization of ALS in the Clinic.

Authors:  Jennifer Roggenbuck; Kelly A Rich; Leah Vicini; Marilly Palettas; Joceyln Schroeder; Christina Zaleski; Tara Lincoln; Luke Drury; Jonathan D Glass
Journal:  Neurol Genet       Date:  2021-08-10

2.  High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.

Authors:  Serena Lattante; Giuseppe Marangi; Paolo Niccolò Doronzio; Amelia Conte; Giulia Bisogni; Marcella Zollino; Mario Sabatelli
Journal:  Genes (Basel)       Date:  2020-09-24       Impact factor: 4.096

3.  NEK1 Variants in a Cohort of Italian Patients With Amyotrophic Lateral Sclerosis.

Authors:  Nilo Riva; Laura Pozzi; Tommaso Russo; Giovanni Battista Pipitone; Paride Schito; Teuta Domi; Federica Agosta; Angelo Quattrini; Paola Carrera; Massimo Filippi
Journal:  Front Neurosci       Date:  2022-04-14       Impact factor: 5.152

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.